March 13, 2025

Biotech

Tasso and ARUP Laboratories Announce Partnership, Combined Offering for Decentralized Clinical Research Biomarker Testing | Newswise

Tasso and ARUP Laboratories Announce Partnership, Combined Offering for Decentralized Clinical Research Biomarker Testing | Newswise

David Bale05 mins

Newswise — SEATTLE and SALT LAKE CITY, Feb. 3, 2025  — Tasso Inc., the leading provider of patient-centric, clinical grade blood collection solutions, and ARUP Laboratories, the largest nonprofit clinical and academic reference laboratory in the United States, today announced that they have entered into a partnership to develop and operationalize high-quality, at-home, blood testing…

Read More
Penn Medicine’s Susan Domchek, MD, Honored by ASCO for Cancer Prevention Work | Newswise

Penn Medicine’s Susan Domchek, MD, Honored by ASCO for Cancer Prevention Work | Newswise

David Bale06 mins

Newswise — PHILADELPHIA – Susan M. Domchek, MD, FASCO, has been recognized by the American Society of Clinical Oncology (ASCO) with one of the society’s highest honors, as the 2025 recipient of the ASCO-American Cancer Society Cancer Prevention Award. Domchek is the Basser Professor in Oncology in the Perelman School of Medicine at the University of Pennsylvania, and executive…

Read More
Penn Medicine’s Susan Domchek, MD, Honored by ASCO for Cancer Prevention Work | Newswise

Microvesicles Derived From Mesenchymal Stem Cells: A Promising Therapeutic Strategy for Acute Respiratory Distress Syndrome-Related Pulmonary Fibrosis? | Newswise

David Bale02 mins

Newswise — Pulmonary fibrosis significantly contributes to the pathogenesis of acute respiratory distress syndrome (ARDS), markedly increasing patient mortality. Despite the established anti-fibrotic effects of mesenchymal stem cells (MSCs), numerous challenges hinder their clinical application. A recent study demonstrated that microvesicles (MVs) from MSCs (MSC-MVs) could attenuate ARDS-related pulmonary fibrosis and enhance lung function via…

Read More
Penn Medicine’s Susan Domchek, MD, Honored by ASCO for Cancer Prevention Work | Newswise

Cell Painting Technology Holds Promise for Drug Discovery | Newswise

David Bale04 mins

Newswise — The Institute for Research in Immunology and Cancer of the Université de Montréal (IRIC) high-throughput screening platform has been awarded $583,654 by Quebec’s Ministère de l’Économie, de l’Innovation et de l’Énergie, following a call for projects launched as part of the Quebec Research and Innovation Investment Strategy 2022-2027 (SQRI2). The funded project aims…

Read More
Study Finds Three New Safe, Effective Ways To Treat Drug-Resistant Tuberculosis | Newswise

Study Finds Three New Safe, Effective Ways To Treat Drug-Resistant Tuberculosis | Newswise

David Bale09 mins

At a glance: Study finds three new safe and effective drug regimens to fight multidrug-resistant TB The treatments, which include recently discovered TB drugs, give new options for shorter, personalized treatment and are cleared for use for more people than ever Newswise — Tuberculosis remains one of the top infectious disease killers worldwide, a challenge…

Read More
Penn Medicine’s Susan Domchek, MD, Honored by ASCO for Cancer Prevention Work | Newswise

Bone Marrow Mesenchymal Stem Cells Promote Uterine Healing by Activating the pi3k/Akt Pathway and Modulating Inflammation in Rat Models | Newswise

David Bale04 mins

BACKGROUND Newswise — Uterine injury can cause uterine scarring, leading to a series of complications that threaten women’s health. Uterine healing is a complex process, and there are currently no effective treatments. Although our previous studies have shown that bone marrow mesenchymal stem cells (BMSCs) promote uterine damage repair, the underlying mechanisms remain unclear. However,…

Read More
MD Anderson Research Highlights for January 22, 2025 | Newswise

MD Anderson Research Highlights for January 22, 2025 | Newswise

David Bale012 mins

HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Novel allogeneic NK cell therapy from induced pluripotent…

Read More
AllSci Launches AI Development Partner Program to Accelerate Pharmaceutical and Biotechnology R&D | Newswise

AllSci Launches AI Development Partner Program to Accelerate Pharmaceutical and Biotechnology R&D | Newswise

David Bale04 mins

Newswise — NORTH BETHESDA, Md., Jan. 23, 2025 — AllSci has opened its Development Partner Program to R&D-driven life science organizations seeking to leverage the power of its revolutionary AI platform. This exclusive program offers early access to AllSci’s proprietary pharmaceutical hypothesis database, advanced visualization engine, and AERIS—AllSci’s cutting-edge AI purpose-built for research and scientific knowledge…

Read More